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Gene expression variance based on random sequencing in rat
remnant kidney.
Background. Several examinations have been performed to
identify the genes involved in chronic renal failure using 5/6
nephrectomized rats. Recently, many systematic techniques for
examining molecular expression have been developed. They
might also be effective in elucidating the molecular mechanism
of progressive renal failure. In this study, digital expression pro-
filing was carried out to construct a subtractive mRNA expres-
sion database for the 5/6 nephrectomized kidney.
Methods. One thousand clones were randomly sequenced
from 5/6 nephrectomized and sham-operated rat kidney cDNA
libraries, respectively, and defined by BLAST search. In silico
subtractive analysis was performed to search for genes up- or
down-regulated in the 5/6 nephrectomized kidney.
Results. The growth factor-related mRNAs and the
mRNAs encoding cytoskeletal or membrane proteins were
up-regulated, but the transporter-related mRNAs were down-
regulated in the 5/6 nephrectomized kidney database. In silico
subtraction revealed that 63 mRNAs were increased and 59
were decreased in the 5/6 nephrectomized kidney. To confirm
whether the in silico subtractive database reflected the actual ex-
pression of mRNA or protein, 12 known genes were examined
by Northern blotting or immunoblotting, respectively. The ac-
tual expression of the 12 genes was comparable with the results
of in silico subtraction. In addition, we successfully isolated five
unknown genes, two up-regulated and three down-regulated in
the 5/6 nephrectomized kidney.
Conclusion. We constructed a subtractive mRNA expres-
sion database for 5/6 nephrectomized kidney, which reflects the
actual alterations in mRNA expression after subtotal nephrec-
tomy. This database may be useful for elucidation of the molec-
ular mechanism of progressive renal failure.
Five-sixth nephrectomized rats are widely used as a
model of progressive renal failure [1, 2]. There are several
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findings in which specific genes have been up-regulated
or down-regulated in the 5/6 nephrectomized kidney.
One to 4 weeks after 5/6 nephrectomy, the genes related
to hypertrophy, development of glomerular sclero-
sis, or vascular tone, such as transforming growth
factor b (TGF-b), insulin-like growth factor (IGF)
and so on, are up-regulated in the remnant kidney
[3–8]. On the other hand, organic ion transporters
OAT-K and OCT-2 in proximal tubules were down-
regulated in the 5/6 nephrectomized kidneys [9, 10].
However, the kidney is a heterogeneous tissue with many
types of cell and the progression of chronic renal fail-
ure (CRF) involves many factors. Therefore, analysis of
overall genes should be done to understand further the
molecular mechanisms of progressive CRF.
To date, many systematic techniques have been de-
veloped to analyze molecular expression. Polymerase
chain reaction (PCR)-coupled representational differ-
ence analysis (RDA-PCR) [11], differential display [12],
cDNA microarray [13, 14], and so on are examples.
Digital expression profiling is one of the methods of
large-scale gene expression analysis in which the mRNA
population in a given tissue is assessed quantitatively by
sequencing randomly selected clones from a 3′-directed
cDNA library [15, 16]. Recently, Takenaka et al [17, 18]
constructed cDNA databases for mouse proximal tubules
and collecting ducts, and successfully obtained informa-
tion on the expression profile of normal kidney.
The isolation of genes up-regulated in 5/6 nephrec-
tomized mouse kidneys using RDA-PCR was previ-
ously reported by Zhang et al [19]. Ten known genes
and nine novel genes were isolated in that study.
Although this method is advantageous for screening ap-
parently up-regulated genes, it is difficult to isolate all up-
regulated genes unless thousands of clones are screened
[19]. In addition, the relative expression level could not
be determined by this method. Taken together, RDA-
PCR would certainly be effective for searching for up-
regulated genes; however, it would be insufficient for
screening for massive physiologic variation in progressive
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renal failure. Therefore, we adopted the digital expres-
sion profiling to identify up- or down-regulated genes si-
multaneously in progressive renal failure.
Recently we have identified an Na+-dependent glucose
transporter (rNaGLT1) from a rat kidney cDNA library
by the digital expression profiling [20]. rNaGLT1 is abun-
dantly expressed and considered to be critical for glucose
and fructose reabsorption in renal proximal tubules [20,
21]. Thus, this method would be useful for cloning novel
genes, which are abundantly expressed and are physi-
ologically important. Applying this method to disease
models may be beneficial for identifying some genes re-
lated to pathophysiologic status. In this study, we con-
structed a cDNA database of 5/6 nephrectomized and
sham-operated rat kidneys 2 weeks after 5/6 nephrec-
tomy by this method. The aim of this study was to con-
struct a subtractive mRNA expression database for the
5/6 nephrectomized kidney, and find novel genes up- or
down-regulated by subtotal nephrectomy.
METHODS
Materials
Vancomycin and cisplatin were purchased from Sh-
ionogi Co. (Osaka, Japan) and Bristol-Myers Squibb Co.
(Tokyo, Japan), respectively. Protease inhibitor cocktail
was obtained from Calbiochem (San Diego, CA, USA).
Antirat osteopontin antibody was from Immuno Biolog-
ical Laboratories Co. (Gunma, Japan). Antirat cathepsin
B antibody and antimouse Na+-K+ATPase a1 subunit
antibody were from Upstate Biotechnology Co. (Lake
Placid, NY, USA). All other chemicals were of the high-
est purity available.
Animals
Male Wistar albino rats were purchased from SLC
Animal Research Laboratories, and cared for in accor-
dance with the Guidelines for Animal Experiments of
Kyoto University. The animals were fed normal pellet
food ad libitum, and given water freely. To induce 5/6
nephrectomy, 7-week-old male rats weighing 200 to 220 g
were surgically operated as previously described [9, 10].
Briefly, the right kidneys were removed, and the posterior
and anterior apical segmental branches of the left renal
artery were individually ligated. Two weeks after surgery,
the rats were placed in metabolic cages for the collec-
tion of 24-hour urine samples used for measurements
of urinary creatinine and N-acetyl-b-D-glucosaminidase
(NAG) excretion. Blood was collected from a cervical
vein for the measurement of plasma creatinine and blood
urea nitrogen (BUN). Creatinine was measured using the
Jaffe´ method with commercial kits (Wako Pure Chemi-
cal Industries, Osaka, Japan). BUN was measured with
i-STAT Portable Clinical Analyzer (i-STAT Co., East
Windsor, NJ, USA) as described elsewhere [22]. NAG
was measured using commercial kits (Shionogi Co.). Uri-
nary albumin was assessed using an enzyme-linked im-
munosorbent assay (ELISA) kit (Nephrat II) (Exocell,
Inc., Philadelphia, PA, USA).
To induce nephrotoxicity with cisplatin or vancomycin,
9-week-old male rats weighing 290 to 310 g were adminis-
tered cisplatin intraperitoneally (6 mg/kg) or vancomycin
intravenously (500 mg/kg) [23]. Vehicle control rats were
administered saline intravenously (10 mL/kg). Two days
after the administration, the rats were placed in metabolic
cages, and biochemical parameters of blood and urine
were measured as described above.
Construction of a rat kidney cDNA library
Rat kidney total RNA was extracted from eight 5/6
nephrectomized or four sham-operated rats by guani-
dine isothiocyanate-CsCl ultracentrifugation, 2 weeks
after nephrectomy. The poly(A)+ RNA was purified
with oligo(dT)-cellulose (Stratagene, La Jolla, CA, USA)
affinity column chromatography, as described previously
[24]. The creatinine clearance of 5/6 nephrectomized rats
used in the construction of the cDNA library was sig-
nificantly lower than that of sham-operated rats (5/6
nephrectomized rats 2.0 ± 0.2 mL/min/kg, sham-operated
rats 4.1 ± 0.5 mL/min/kg, mean ± SE of eight and four
rats, respectively). After confirmation of induction of
the appropriate nephropathy by creatinine clearance,
the poly(A)+ RNA isolated from sham-operated or 5/6
nephrectomized rat kidneys was used to construct the
cDNA libraries. The libraries were constructed using the
kZAP Express cDNA Synthesis Kit (Stratagene) accord-
ing to the manufacturer’s instructions. Briefly, cDNA was
synthesized using a linker primer, and digested by the re-
striction enzyme XhoI. To remove excess adaptor and to
concentrate the complete length of cDNA, the cDNA was
size-fractionated with cDNA Size Fraction Columns (In-
vitrogen Life Technology Co., Carlsbad, CA, USA). The
cDNA was ligated in kZAP expression vector and excised
out of the phage in the form of the pBK-cytomegalovirus
(CMV) phagemid vector. The phagemid vectors with
the cDNA inserts were transferred into Escherichia coli
(strain XLOLR). From these cDNA libraries, 1033 (5/6
nephrectomized kidney) and 1015 (sham-operated kid-
ney) randomly selected colonies were sequenced using
a Multi-Capillary DNA Sequencing System RISA-384
(Shimadzu Co., Kyoto, Japan).
Data analysis
The isolated clones were partially sequenced (500–
550 bp) from the 5′ end using T3 primer, and the result-
ing sequences were searched against GenBank, EMBL,
DDBJ, and PDB using the BLAST program. If the Ex-
pect value (E value) was less than 10−50 (1e-50), the clone
was regarded as representing the corresponding gene. A
clone with an E value of more than 1e-50 was identified as
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a “novel gene.” The novel genes were further sequenced
from the 3′ end using T7 primer. The poly(A)+ tail was
eliminated from the sequencing data. If overlapping re-
gions had more than 90% homology, the two sequences
were considered identical. The subtractive database of
the 5/6 nephrectomized kidney and the sham-operated
kidney was created in silico. The criteria of a significant
difference in the subtractive difference was defined as fol-
lows; a frequency in one database was threefold higher
than that in the other database and the frequency in the
subtractive database was required at least two.
Western blotting
The rat whole kidney was homogenized in sucrose
buffer (250 mmol/L sucrose, 5 mmol/L Tris-Hepes, pH
7.4, and 1% protease inhibitor cocktail). The tissue
lysate was sonicated and clarified by centrifugation [lysis
buffer 50 mmol/L Tris-HCl, pH 7.4, 1% NP-40, 0.25%
sodium deoxycholate, 150 mmol/L NaCl, 1 mmol/L
ethyleneglycol tetraacetate (EGTA), and 1% protease
inhibitor cocktail]. The crude membrane fractions of the
rat kidney were prepared as described [25]. The kidney
lysate was used for analysis of cathepsin B, and the
membrane fraction was used for osteopontin, OAT1, and
the Na+-K+ATPase a1 subunit. The lysate (20 lg) or the
membrane fraction (25 lg) was separated by 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to polyvinylidene diflu-
oride (PVDF) membranes (Hybond-PVDF) (Amer-
sham Biosciences, Piscataway, NJ, USA) by semidry
electroblotting for 35 minutes. The blots were blocked,
washed, and incubated with the primary antibodies
overnight at 4◦C. The bound antibody was detected
on x-ray film by enhanced chemiluminescence (ECL)
with a horseradish peroxidase-conjugated antirabbit or
antimouse IgG antibody and cyclic diacylhydrazides
(Amersham Biosciences).
Northern blotting
The rat kidney total RNA was extracted using
RNeasy kit (Qiagen, Inc., Hilden, Germany), according
to the manufacturer’s directions. Five micrograms of total
RNA was electrophoresed in a 1% denaturing agarose
gel containing formaldehyde and transferred onto
Hybond N+ nylon membranes (Amersham Bio-
sciences). The transferred RNAs were linked to the nylon
membrane by an ultraviolet cross linker. The quality of
RNA was assessed by ethidium bromide staining. After
transfer, the blots were hybridized under high stringency
conditions [50% formamide, 5 × sodium chloride sodium
phosphate EDTA buffer (SSPE)] [20 × SSPE; 3 mol/L
NaCl, 0.2 mol/L NaH2PO4, and 0.02 mol/L ethylenedi-
aminetetraactetic acid (EDTA), pH 7.4], 5 × Denhardt’s
solution, 0.1% SDS, and 10 lg/mL of herring sperm DNA
at 42◦C) with each cDNA insert labeled with [a-32P]
deoxycytidimine triphosphate (dCTP) (29.6 TBq/mmol)
(Amersham Biosciences). After hybridization, the blots
were washed three times with 2× sodium chloride sodium
citrate buffer (SSC) (20 × SSC; 3 mol/L NaCl and
0.3 mol/L sodium citrate, pH 7.0) containing 0.1% SDS at
42◦C for 10 minutes, and then twice with 0.5 × SSC/0.1%
SDS at 42◦C for 30 minutes. The dried membranes were
exposed to the imaging plates of Fujix BIO-imaging An-
alyzer BAS-2000 II (Fuji Photo Film Co., Tokyo, Japan).
As nonspecific hybridization was observed in the de-
tection of 4F2hc mRNA using full-length probe, North-
ern blotting of 4F2hc was performed with a digoxigenin
(DIG)-labeled probe corresponding to nucleotide po-
sitions 660–1074. The probe was labeled with DIG us-
ing PCR DIG probe synthesis kit (Roche Diagnostics,
Mannheim, Germany) according to the manufacturer’s
instructions. Hybridization was performed as described
above. After hybridization, the blots were washed twice
with 2 × SSC/0.1% SDS for 10 minutes, and then three
times with 0.5 × SSC/0.1% SDS for 20 minutes. DIG-
labeled nucleic acids were detected using a DIG lumi-
nescent detection kit (Roche Diagnostics), according to
the manufacturer’s directions.
Microdissection of rat nephron segments
The rat nephron was microdissected as described previ-
ously [26]. Briefly, the left kidneys of 5/6 nephrectomized
and sham-operated rats 2 weeks after subtotal nephrec-
tomy were perfused and removed. Slices were cut along
the medullary axis and incubated with collagenase. The
tubules were microdissected to obtain the following struc-
tures: glomerulus, proximal convoluted tubule (PCT),
proximal straight tubule (PST), medullary thick ascend-
ing limb (MAL), cortical thick ascending limb (CAL),
cortical collecting duct (CCD), outer medullary collect-
ing duct (OMCD), and inner medullary collecting duct
(IMCD). After microdissection, 20 glomeruli and 8 mm
of each dissected tubule segment were transferred into
tubes to isolate total RNA using RNeasy minikit
(Qiagen).
RT-PCR analysis
Total RNA from the dissected tubules and poly(A)+
RNA from rat tissues (brain, heart, lung, liver, small in-
testine, spleen, kidney cortex, and kidney medulla) was
reverse-transcribed with random hexamers, using Super-
script II reverse transcriptase (Invitrogen), followed by
RNase H (Invitrogen) digestion. These single-stranded
DNA fragments were amplified with primer sets specific
for the five unknown genes.
Analysis of novel or unknown genes
There were 343 mRNAs in which the nucleic acid
and amino acid sequences have been clarified with little
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information available concerning their functions and tis-
sue distributions (about 17% of 2048 clones sequenced).
We identified them as “unknown genes.” There were
18 novel or unknown genes appearing twice either in
the 5/6 nephrectomized or in the sham-operated kid-
ney. Among them, five genes were fully sequenced be-
cause significant differences in expression were shown
between the 5/6 nephrectomized and sham-operated kid-
ney by Northern blotting. To analyze the 5′ upstream
region, a 5′ rapid amplification of cDNA ends (RACE)
was performed using Marathon-Ready cDNA kits (Clon-
tech Laboratories, Inc., Palo Alto, CA, USA). The motifs
of their deduced amino acid sequences were searched
against Smart (Simple Modular Architecture Research
Tool, smart.embl-heidelberg.de/) and Pfam (Protein fami-
lies database of alignments and HMMs, pfam.wust1.edu/)
libraries. In addition, the tissue distribution, the local-
ization along the nephron, the expression in the earlier
phases of 5/6 nephrectomized rats, and the expression in
acute nephropathy induced by cisplatin or vancomycin of
these five unknown genes were examined.
Statistical analysis
Data are expressed as the mean ± SEM. Data were
analyzed statistically by the unpaired Student t test, or
by a one-way analysis of variance (ANOVA) followed
by Fisher’s t test, when multiple comparisons against the
control were needed. Significance was set at P < 0.05.
RESULTS
Gene expression profiles and in silico subtraction
In the 5/6 nephrectomized kidney, there were 41 genes
highly expressed (more than three times), 84 genes ex-
pressed twice, and 663 genes expressed once. In total,
788 genes were found. In the sham kidney, there were 46
genes highly expressed, 79 genes expressed twice, and 594
genes expressed once, a total of 729. These isolated genes
were classified according to function and localization. The
results are shown in Table 1. In the 5/6 nephrectomized
kidney, the growth factor-related mRNA and the mRNA
encoding cytoskeletal or membrane proteins were in-
creased compared with those in the sham-operated kid-
ney. In contrast, the genes related to the transporter were
decreased in the 5/6 nephrectomized kidney.
In the 5/6 nephrectomized kidney, 853 clones were
identical to previously reported genes, but 168 clones
among them were classified as unknown genes. There
were 180 clones for which the E value of the BLAST
homologue analysis was more than 1e-50 and thought
to be novel genes. Among them, 12 clones were consid-
ered to be duplicated, as their sequences at the 3′ end
were identical. As a result, we obtained 174 novel genes
in the 5/6 nephrectomized kidney. In the sham-operated
Table 1. Classification of mRNA in the 5/6 nephrectomized and
sham-operated kidney according to function or localization
5/6 Nephrectomy Sham-operated
Category frequency % frequency %
Cytoskeletal, 73 7.1 37 3.6
membrane
protein
Growth 15 1.5 4 0.4
factor–related
Ribosome 27 2.6 19 1.9
Heat shock protein 5 0.5 7 0.7
Metabolic enzyme 29 2.8 31 3.1
Enzyme 183 17.7 227 22.4
Protease 29 2.8 27 2.7
Nuclear factor 66 6.4 54 5.3
Mitochondria 53 5.1 46 4.5
Signal transduction 54 5.2 52 5.1
Transporter 24 2.3 37 3.6
Receptor channel 17 1.6 14 1.4
Endocytosis 15 1.5 15 1.5
Other 95 9.2 106 10.4
Unknown; 168 16.3 175 17.2
function
unknown
Unknown; novel 180 17.4 164 16.2
Total 1033 100.0 1015 100.0
Frequency and percentages of clones classified into 16 categories are listed.
“Other” means a clone not classified into the above 13 categories.
kidney, 851 clones were identical to previously reported
genes, but 175 clones among them were unknown genes.
There were 164 clones classified as novel genes. Among
them, 14 clones were judged to be duplicated, based on
the sequence of the 3′ end. As a result, 157 novel genes
were observed in the sham-operated kidney.
In silico subtraction of the 5/6 nephrectomized and the
sham-operated kidney databases was performed. Sixty-
three genes were increased (Table 2) and 59 decreased in
the 5/6 nephrectomized kidney (Table 3).
Confirmation of the database
To confirm whether the in silico subtractive database
of 5/6 nephrectomized kidney reflected the actual expres-
sion of mRNA, the expression of 12 genes which was
considered to be common in the kidney was examined by
Northern blotting in five 5/6 nephrectomized and sham-
operated rats at 2 weeks after surgery. A summary of
the 12 genes is described in Table 4. Because the mRNA
database to reflect not only mRNA expression level but
also protein expression level is important to elucidate
the mechanisms of progressive nephropathy, the expres-
sional changes of cathepsin B, osteopontin, OAT1, and
the Na+-K+ATPase a1 subunit, whose specific antibodies
were available, were also examined by Western blotting.
The blood and urine biochemical parameters and kidney
weights are shown in Table 6. Decreases in creatinine
clearance and albuminuria were found in the 5/6 nephrec-
tomized rats, but urinary NAG excretion, an indicator
of proximal tubule injury, was not significantly changed.
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Table 2. The mRNAs up-regulated in the 5/6 nephrectomized (NR) kidney database by in silico subtraction
Frequency Sham- Accession
NR operated Gene name Category number
5 0 Rat liver aldolase B mRNA, complete cds Enzyme M10149
5 0 Rattus norvegicus cytochrome b, mRNA Mitochondria AF295545
4 0 Rat mRNA for sulfated glycoprotein 2 Other AB013455
4 0 Rattus norvegicus cathepsin B (Ctsb), mRNA Protease X13231
4 0 Rattus norvegicus mRNA for NaPi-2 gamma, complete cds Transporter NM 022597
4 1 Rattus norvegicus cytochrome P450, 4a10 (Cyp4a10),
mRNA
Metabolic enzyme NM 031605
4 1 Rattus norvegicus eukaryotic translation elongation factor
2 (Eef2), nRNA
Nuclear NM 017245
3 0 Rattus norvegicus CD24 antigen (Cd24), mRNA Other NM 013457
3 0 Rattus norvegicus kidney injury molecule-1 (KIM-1),
mRNA, complete cds
Other BC006660
3 0 Rattus norvegicus 3-hydroxyanthranilate 3,4-dioxygenase
(Haao), mRNA
Enzyme NM 020076
3 0 Rattus norvegicus glutamate-cysteine ligase regulatory,
mRNA
Enzyme NM 012752
3 0 Mus musculus adducin 1 (alpha) (Add1), mRNA Cytoskeletal, membrane
protein
AF219904
3 0 Rattus norvegicus folate binding protein, mRNA,
complete cds
Cytoskeletal, membrane
protein
NM 017305
3 0 Rattus norvegicus Sialoprotein (osteopontin) (Spp1),
mRNA
Cytoskeletal, membrane
protein
AF035963
3 0 Rattus norvegicus ubiquitin C (Ubc), mRNA Protease NM 017341
3 0 Rattus norvegicus similar to NADH-ubiquinone
oxidoreductase 75 kD subunit
Mitochondria NM 012881
3 1 Rat leukemia virus gag (gag), polymerase, and envelope
protein genes, complete cds
Enzyme AK004990
3 1 Rat mRNA for preprocathepsin D (EC 3.4.23.5) Protease M77194
3 1 Rattus norvegicus similar to claudin 2 Cytoskeletal, membrane
protein
XM236535
2 0 Mus musculus alpha-2 type IV collagen, mRNA, complete
cds
Other J04695
2 0 Mus musculus interferon regulatory factor 3 (Irf3), mRNA Other NM 016849
2 0 Mus musculus procollagen, type VI, alpha 1 (Col6a1),
mRNA
Other NM 009933
2 0 Rattus norvegicus peroxiredoxin 3 (Prdx3), mRNA Other NM 022540
2 0 Mus musculus, ELK3, member of ETS oncogene family,
clone MGC:11528
Other BC005686
2 0 HSD IV = peroxisome proliferator-inducible gene [rats,
F344, liver, mRNA partial, 2480 nt]
Enzyme S83279
2 0 Mus musculus serine hydroxymethyltransferase, mRNA,
complete cds
Enzyme AF237702
2 0 Rat mRNA for glutamine synthetase (EC 6.3.1.2.) Enzyme X07921
2 0 Rattus norvegicus cysteine desulfurase (NifS), mRNA,
complete cds
Enzyme AF336041
2 0 Rattus norvegicus D-dopachrome tautomerase (Ddt),
mRNA
Enzyme NM 024131
2 0 Rattus norvegicus kynurenine aminotransferase II (Kat2),
mRNA
Enzyme NM 017193
2 0 Rattus norvegicus mRNA for H(+)-transporting ATPase,
complete cds
Enzyme D10874
2 0 Rattus norvegicus NG,NG dimethylarginine
dimethylaminohydrolase (Ddah1), mRNA
Enzyme D86041
2 0 Rattus norvegicus ornithine aminotransferase (Oat),
mRNA
Enzyme NM 022521
2 0 Rattus norvegicus protein disulfide isomerase, mRNA Enzyme NM 012998
2 0 Rattus norvegicus insulin-like growth factor binding
protein 1 (Igfbp1), mRNA
Growth factor–related NM 013144
2 0 Mus musculus destrin (Dsn-pending), mRNA Cytoskeletal, membrane
protein
NM 019771
2 0 Mus musculus presenilin-1 gene, alternatively spliced
transcripts, complete cds
Cytoskeletal, membrane
protein
AF007560
2 0 Rat brain calbindin-d28k (CaBP28K), mRNA Cytoskeletal, membrane
protein
M27839
2 0 Rattus norvegicus mRNA for neuronal beta-catenin like
protein (ORF1)
Cytoskeletal, membrane
protein
AJ301634
2 0 Rattus sp. liver tricarboxylate carrier, mRNA Mitochondria S70011
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Table 2. Continued.
Frequency Sham- Accession
NR operated Gene name Category number
2 0 Mus musculus adult male kidney cDNA, RIKEN
fclone:0610007F03
Mitochondria AK018712
2 0 Mus musculus histone deacetylase 5 (Hdac5), mRNA Nuclear NM 010412
2 0 Rattus norvegicus mRNA for ribonucleoprotein F,
complete cds
Nuclear NM 022397
2 0 Human DNA sequence from clone 486I3 on chromosome
6q22.1–22.3
Nuclear AL050331
2 0 Homo sapiens 5-HT receptor, mRNA, complete cds Receptor channel AF251055
2 0 Mus musculus chloride intracellular channel 4
(mitochondrial) (Clic4), mRNA
Receptor channel NM 013885
2 0 Homo sapiens cDNA FLJ13989 fis, clone Y79AA1002083 Ribosome AK024051
2 0 Homo sapiens, clone IMAGE:2820942, mRNA, partial cds Ribosome BC006474
2 0 Mus musculus N-myc downstream regulated 3 (Ndr3),
mRNA
Signal transduction NM 013865
2 0 Mus musculus pyruvate kinase 2 (pkm2), mRNA Signal transduction NM 011099
2 0 Rat casein kinase I delta, mRNA, complete cds Signal transduction L07578
2 0 Rattus norvegicus 14-3-3-zeta isoform (Prkcz), mRNA Signal transduction U37252
2 0 Rattus norvegicus mRNA for inositol hexakisphosphate
kinase, complete cds
Signal transduction AB049151
2 0 Rattus norvegicus rap7a (Rap7a), mRNA Signal transduction NM 022526
2 0 R.norvegicus mRNA for monocarboxylate transporter Transporter X86216
2 0 Mus musculus 10, 11 days embryo cDNA, RIKEN
clone:2810413P16
Unknown BC011420
2 0 Mus musculus 10 days embryo cDNA, RIKEN
clone:2610315D18
Unknown AK012030
2 0 Rattus norvegicus 4 BAC CH230-5L13 Unknown AC126722
2 0 Rattus norvegicus similar to hypothetical protein
MGC14421
Unknown AC126722
2 0 Mus musculus ES cells cDNA, RIKEN clone:2410083E08 Unknown AK010737
2 0 Novel gene 1 Novel
2 0 Novel gene 2 Novel
2 0 Novel gene 3 Novel
The mRNAs, which were more frequent in the 5/6 nephrectomized kidney database compared with sham-operated kidney database, were listed. Significant difference
was defined when the frequency of 5/6 nephrectomized kidney database was threefold higher than that of sham-operated kidney database and the subtractive difference
was more than two.
The residual kidneys, which were removed necrotic re-
gion, were actually enlarged twofold in the 5/6 nephrec-
tomized rats, as the weights of the 5/6 nephrectomized
kidney were about one third those of the sham-operated
kidneys despite 5/6 ablations.
The results of Northern blotting and Western blot-
ting are shown in Figure 1. The mRNA expression
of cathepsin B, osteopontin, kidney injury molecule-1
(KIM-1), and insulin-like growth factor binding protein-1
(IGFBP1) was significantly increased in the 5/6 nephrec-
tomized kidney (Fig. 1A). The mRNA expression of
OAT1, Na+-K+ATPase a1 subunit, elongation factor 1a,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
and aquaporin 2 was maintained in the 5/6 nephrec-
tomized kidney (Fig. 1B). However, the mRNA expres-
sion of phenylalanine hydroxylase, 4F2hc, and OCTN2
was significantly decreased in the 5/6 nephrectomized
kidney (Fig. 1C). These results were well comparable
with the in silico subtractive database (Tables 2 and 3).
In addition, the protein expression of cathepsin B, os-
teopontin, OAT1, and Na+-K+ATPase a1 subunit were
also comparable with the in silico subtractive database
(Fig. 1).
Novel or unknown genes differentially expressed
between the 5/6 nephrectomized and sham-operated
kidneys
There were eight novel or unknown genes appearing
twice in the 5/6 nephrectomized and 0 times in the sham-
operated kidney database (Table 2). Among them, the ex-
pression of two genes designated UR-NR (up-regulated
in the 5/6 nephrectomized kidney) #1 (GenBank Acces-
sion No. AB108667) and #2 (GenBank Accession No.
AB108668) (the nucleotide sequences reported in this
article have been submitted to GenBank with accession
numbers between AB108667 and AB108671) was sig-
nificantly increased in the 5/6 nephrectomized kidney
as determined by Northern blotting (Fig. 2A and B).
There were 10 novel or unknown genes appearing twice
in the sham-operated and 0 times in the 5/6 nephrec-
tomized kidney database (Table 3). Among them, three
genes designated DR-NR (down-regulated in the 5/6
nephrectomized kidney) #1 (GenBank Accession No.
AB108669), #2 (AB108670), and #3 (AB108671) had a
significantly decreased expression in the 5/6 nephrec-
tomized kidney as shown by Northern blotting (Fig. 2C
to E).
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Table 3. The mRNAs down-regulated in the 5/6 nephrectomized (NR) kidney database by in silico subtraction
Frequency Sham- Accession
NR operated Gene name Category number
0 7 Rattus norvegicus phenylalanine hydroxylase (Pah), mRNA Enzyme NM 012619
2 7 Rattus norvegicus urmodulin (Tamm-Horsfall protein) (Umod), mRNA Other NM 011044
1 7 Mus musculus phosphoenolpyruvate carboxykinase 1, cytosolic (Pck1), mRNA Enzyme NM 017082
2 6 Rattus norvegicus cytochrome P450 arachidonic acid epoxygenase, mRNA Metabolic enzyme U04733
0 5 Rattus norvegicus intestinal type II membrane glycoprotein 4F2hc, mRNA Transporter U59324
1 5 Mus musculus, similar to glutathione S-transferase theta 1, clone MGC:6769, mRNA Enzyme BC003903
0 4 Rattus norvegicus acyl-coenzyme A dehydrogenase, C-4 to C-12 straight-chain, mRNA Enzyme NM 013113
0 4 Rattus norvegicus pyruvate dehydrogenase kinase 2 subunit p45 (PDK2) (Pdk2), mRNA Signal transduction NM 016986
0 4 Rattus norvegicus ATPase Na+/K+ transporting beta 1 polypeptide (Atp1b1), mRNA Transporter NM 030872
1 4 Rat mRNA for cerebellar Ca-binding protein, spot 35 protein Cytoskeletal, NM 031984
membrane
protein
0 3 Rattus norvegicus calreticulin (Calr), mRNA Other NM 022399
0 3 Rattus norvegicus spp-24 precursor, mRNA, partial cds Other NM012570
0 3 Rattus norvegicus glutamate dehydrogenase (Glud1), mRNA Enzyme U19485
0 3 Rattus norvegicus thyroxine deiodinase, type I (Dio1), mRNA Enzyme NM 012653
1 3 Mus musculus, similar to NADH dehydrogenase Fe-S protein 2, clone IMAGE:3600832 Enzyme BC003898
1 3 Rat mRNA for gamma-glutamyl transpeptidase (EC 2.3.2.2) Enzyme X15443
1 3 Rattus norvegicus methylmalonate semialdehyde dehydrogenase gene (Mmsdh), mRNA Enzyme AF359355
1 3 Rattus norvegicus retinol dehydrogenase type II, mRNA, complete cds Enzyme NM 031057
1 3 Rattus norvegicus superoxide dimutase 3 (Sod3), mRNA Enzyme U33500
1 3 Rattus norvegicus membrane-bound aminopeptidase P, mRNA, complete cds Protease NM 012880
0 2 Rattus norvegicus (rsec6), mRNA, complete cds Other U32575
0 2 Rattus norvegicus transcobalamin II precursor (Tcn2p), mRNA Other NM 022534
0 2 Rattus norvegicus prosaposin (sulfated glycoprotein, sphingolipid hydrolase activator) Other NM 013013
0 2 Homo sapiens, calcium binding atopy-related autoantigen 1, clone MGC:4521, mRNA Other BC004216
0 2 Mus musculus interferon alpha responsive gene, 15 kD (Ifrg15-pending), mRNA Other NM 022329
0 2 Mus musculus Mpv17-like protein, mRNA, complete cds Other AF305634
0 2 Rattus norvegicus src family associated phosphoprotein 2 (Scap2), mRNA Other NM 130413
0 2 Mus musculus, similar to autocrine motility factor receptor, clone IMAGE:3500628, mRNA Receptor channnel BC003256
0 2 Rattus norvegicus hydroxysteroid dehydrogenase, 11 beta type 1 (Hsd11b1), mRNA Enzyme NM 017080
0 2 Rattus norvegicus pyruvate carboxylase, mRNA, complete cds Enzyme U36585
0 2 Hprt = hypoxanthine phosphoribosyltransferase [rats, mRNA, 853 nt] Enzyme S79292
0 2 Rattus sp. mRNA for argininosuccinate lyase, complete cds Enzyme D13978
0 2 Rattus norvegicus tissue-type transglutaminase (TgaseII), mRNA, complete cds Enzyme AF106325
0 2 Rattus norvegicus cysteine-sulfinate decarboxylase (Csad), mRNA Enzyme NM 021750
0 2 Rattus norvegicus Glutamate oxaloacetate transaminase 2, mitochondrial (Got2), mRNA Enzyme NM 013177
0 2 Homo sapiens heat shock protein 75 (TRAP1), mRNA HSP NM 016292
0 2 Rattus norvegicus vesicle-associated membrane protein 7 (Vamp7) mRNA, complete cds Cytoskeletal, AF281632
membrane
protein
0 2 Homo sapiens, Similar to membrane protein of cholinergic synaptic vesicles, mRNA Cytoskeletal, XM 213485
membrane
protein
0 2 Rat mRNA for mitochondrial long-chain 3-ketoacyl-CoA thiolase beta-subunit Mitochondria D16479
0 2 Mus musculus SMT3 (supressor of mif two, 3) homolog 1 (S. cerevisiae) (Smt3h1), mRNA Nuclear NM 019929
0 2 Mus musculus NUDE-like protein mRNA, complete cds Nuclear AF323918
0 2 Mus musculus microtubule-associated protein 7 (Mtap7), mRNA Nuclear NM 008635
0 2 Mus musculus proteaseome (prosome, macropain) 28 subunit, 3 (Psme3), mRNA Protease NM 011192
0 2 Rattus mRNA for ribosomal protein S2 Ribosome X57432
0 2 Homo sapiens sorting nexin 17 (SNX17), mRNA Signal transduction NM 014748
0 2 Rattus norvegicus solute carrier family 25, member 1 (Slc25a1), mRNA Transporter NM 172577
0 2 Rattus norvegicus solute carrier family 12, member 1 (Slc12a1), mRNA Transporter NM 019134
0 2 Rattus norvegicus organic cation/carnitine transporter (OCTN2) mRNA Transporter AF110416
0 2 Rattus norvegicus Glutathione-S-transferase, alpha type 2 (Gsta2), mRNA Enzyme NM 017013
0 2 Rattus norvegicus similar to hypothetical protein FLJ20356, mRNA Unknown XM 223527
0 2 Mus musculus RIKEN cDNA 2210404O07 gene, mRNA Unknown BC036156
0 2 Mus musculus adult male liver cDNA, RIKEN clone:1300002B20, full insert sequence Unknown AK004845
0 2 Mus musculus ES cells cDNA, RIKEN clone:2410074K14, full insert sequence Unknown AK010721
0 2 Mouse DNA sequence from clone RP23-22K4 on chromosome 2, complete sequence Unknown AL663077
0 2 Homo sapiens hypothetical protein DKFZp564B1162 (DKFZP564B1162), mRNA Unknown NM 031305
2 0 Mus musculus 13 days embryo head cDNA, RIKEN clone:3110030P16 Unknown XM 055115
0 2 Mus musculus NN5H6H tumor-related protein, mRNA, complete cds Unknown AY035213
0 2 Novel gene 4 Novel
0 2 Novel gene 5 Novel
The mRNAs, which were less frequent in the 5/6 nephrectomized kidney database compared with sham-operated kidney database, are listed. Significant difference
was defined when the frequency of 5/6 nephrectomized kidney database was threefold lower than that of sham-operated kidney database and the subtractive difference
was more than two.
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Table 4. The list of genes subjected to confirmation of the database
Frequency Accession
Gene name NR Sham Category number
NR > sham Cathepsin B 4 0 Protease NM022597
Osteopontin 3 0 Cytoskeletal, membrane protein NM012881
KIM-1 3 0 Cytoskeletal, membrane protein AF035963
IGF binding protein1 2 0 Growth factor–related NM013144
NR = sham OAT1 2 4 Transporter AF008221
Na+-K+ATPase a1 2 2 Transporter NM012504
Elongation factor -1a 12 14 Ribosome X61043
GAPDH 4 6 Enzyme NM017008
Aquaporin 2 2 2 Transporter D13906
NR < sham Pah 0 7 Enzyme NM 012619
4F2hc 0 5 Transporter U59324
OCTN2 0 2 Transporter AF110416
Abbreviations are: Accession number, number in Genbank database; frequency, times appeared in 1033 or 1015 sequences; KIM-1, kidney injury molecule-1; IGF,
insulin like growth factor; OAT-1, organic anion transporter 1; Pah, phenylalanine hydroxylase; OCTN2, novel organic cation transporter 2. The expressions of four
genes which were more frequent in the 5/6 nephrectomized (NR) than sham-operated (sham) kidney, five genes which were equally frequent in the 5/6 nephrectomized
and sham-operated kidney, and three genes which were less frequent in the 5/6 nephrectomized than sham-operated kidney, were examined by Northern blotting or
Western blotting. Nucleotide positions of probes are from the sequences published in GenBank/EBI Data Bank.
To obtain more information about these five genes, the
expression levels in the earlier phases of 5/6 nephrec-
tomized kidney, the tissue distribution, the localization
along the microdissected nephron segments, and the ex-
pression levels in the drug-induced acute nephropathy
models were examined. Blood and urine biochemical pa-
rameters and kidney weights are shown in Table 5. Crea-
tinine clearance of 5/6 nephrectomized rats decreased to
2.1 mL/min/kg at 3 days after the operation, and this level
was maintained until 2 weeks. On the other hand, com-
pensatory hypertrophy was not observed in 5/6 nephrec-
tomized kidneys 3 days after the operation, and kidney
weight was increased sequentially according to the com-
pensatory hypertrophy thereafter. Figure 2 shows the
mRNA expression levels of the five unknown genes in
sham-operated and 5/6 nephrectomized kidneys 3 days,
1 week, and 2 weeks after subtotal nephrectomy. The
mRNA expression of UR-NR #1 of 5/6 nephrectomized
kidney was more markedly increased at 1 week than at
2 weeks after the operation (Fig. 2A). The mRNA ex-
pression of UR-NR #2 of 5/6 nephrectomized kidney was
maintained at 3 days after the operation but increased se-
quentially thereafter (Fig. 2B). The mRNA expression of
DR-NR #1 and DR-NR #3 of 5/6 nephrectomized kidney
was maintained at 3 days and 1 week after the operation
and decreased at 2 weeks after the operation (Fig. 2C and
E). The mRNA expression of DR-NR #2 of 5/6 nephrec-
tomized kidney was equally decreased at 1 week and 2
weeks after the operation (Fig. 2D).
Figure 3 shows the mRNA distribution of the five un-
known genes in eight tissues. UR-NR #1 mRNA was de-
tected in all tissues examined except for the small intes-
tine and spleen. UR-NR #2 and DR-NR #1 mRNAs were
strongly detected in the spleen and kidneys, but weakly
detected in other tissues. DR-NR #2 mRNA existed pre-
dominantly in the kidneys. DR-NR #3 mRNA was de-
tected only in the kidney and liver.
mRNA localization of the five unknown genes along
the nephron segments in sham-operated (Fig. 4A) and
5/6 nephrectomized kidneys (Fig. 4B) was examined.
UR-NR #1 mRNA was localized at IMCD in the sham-
operated kidneys. It was detected not only in IMCD
but also in glomerulus, PCT, and PST in 5/6 nephrec-
tomized kidneys. UR-NR #2 mRNA was not detected
either in sham-operated or 5/6 nephrectomized renal
nephron segments, and was thought to exist in the inter-
stitium or blood vessels in the kidneys. DR-NR #1 mRNA
was detected ubiquitously both in sham-operated and 5/6
nephrectomized renal nephron segments except in MAL.
DR-NR #2 mRNA was localized at glomerulus, PCT, and
the collecting duct in sham-operated kidneys, but was
only localized at PCT and IMCD in 5/6 nephrectomized
kidneys. DR-NR #3 mRNA was detected predominantly
in the proximal tubules in sham-operated kidneys, and its
localization shifted to glomerulus or MAL in 5/6 nephrec-
tomized kidneys.
The mRNA expression levels of the five unknown
genes were also examined in acute renal insufficiency in-
duced by the administration of cisplatin or vancomycin.
Blood and urine biochemical parameters and kidney
weights are shown in Table 6. In the cisplatin nephropa-
thy, a marked reduction of renal function, decrease in
creatinine clearance, increases in BUN and urinary NAG
excretion, and albuminuria were observed. However,
there was no change in kidney weight. In contrast to
the cisplatin nephropathy, there was no change in cre-
atinine clearance and only a slight increase of BUN in
the vancomycin nephropathy. Although urinary NAG ex-
cretion was increased, albuminuria did not appear in the
vancomycin nephropathy. The kidney weight of the an-
imals with vancomycin nephropathy was markedly in-
creased. The results of Northern blotting are shown in
Figure 5. The mRNA expression of UR-NR #1 was signif-
icantly increased in the vancomycin but not the cisplatin
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Fig. 1. Northern blotting or Western blotting of the genes up-regulated (A), maintained (B), or down-regulated (C) in the 5/6 nephrectomized
(NR) kidney in the subtractive database. Five micrograms of total RNA of kidneys was hybridized with each probe under high stringency conditions.
The protein expressions of cathepsin B, osteopontin, OAT1, and Na+-K+ATPase a1 subunit, whose antibodies were available, were also examined
by Western blotting. The amounts of mRNA were quantified by densitometry and normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Each column represents the mean ± SEM of five rats. ∗P < 0.05, significantly different from sham (Student unpaired t test). Abbreviations
are: N, Northern blotting; W, Western blotting; KIM-1, kidney injury molecule-1; IGFBP-1, insulin like growth factor binding protein-1; OAT1,
organic anion transporter1; AQP2, aquaporin 2; Pah, phenylalanine hydroxylase; OCTN2, novel organic cation transporter 2.
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Fig. 2. Northern blotting of the five unknown genes in the 5/6 nephrectomized (NR) and sham-operated (sham) kidneys. mRNA expression of up-
regulated 5/6 nephrectomized (UR-NR) #1 (A), UR-NR #2 (B), down-regulated 5/6 nephrectomized (DR-NR) #1 (C), DR-NR #2 (D), and DR-NR
#3 (E) in the 5/6 nephrectomized and sham-operated kidneys 3 days, 1 week, and 2 weeks after the operation was examined. Five micrograms of total
RNA of kidneys was hybridized with each probe under high stringency conditions. The amounts of mRNA were quantified by densitometry and
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Each column represents the mean ± SEM of five rats. ∗P < 0.05, significantly
different from sham-operated (Student unpaired t test).
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Table 5. State of renal function of the 5/6 nephrectomized (NR) and sham-operated (sham) rats 3 days, 1 week, and 2 weeks after subtotal
nephrectomy
Plasma Blood urea Creatinine Urinary excretion Urinary excretion
Body creatinine nitrogen clearance of albumin of NAG Kidney
weight g mg/dL mg/dL mL/min/kg mg/day U/day weight g
Sham 3 days 204 ± 2 0.4 ± 0.0 14 ± 0 7.0 ± 0.5 0.2 ± 0.0 156 ± 15 1.6 ± 0.0
1 week 232 ± 3 0.5 ± 0.0 11 ± 0 5.1 ± 0.4 0.4 ± 0.1 232 ± 19 1.7 ± 0.0
2 weeks 270 ± 4 0.5 ± 0.0 14 ± 2 5.2 ± 0.1 0.3 ± 0.1 211 ± 16 1.7 ± 0.0
NR 3 days 188 ± 3a 1.4 ± 0.1a 56 ± 2a 2.1 ± 0.3a 6.9 ± 1.7a 180 ± 44 0.3 ± 0.0a
1 week 192 ± 5a 1.1 ± 0.1a 48 ± 2a 2.1 ± 0.1a 7.1 ± 2.2a 177 ± 15 0.4 ± 0.0a
2 weeks 230 ± 10a 1.2 ± 0.1a 59 ± 6a 1.9 ± 0.1a 4.0 ± 2.2a 187 ± 11 0.6 ± 0.0a
NAG is N-acetyl-b-D-glucosaminidase.
The urine and blood samples were collected at 3 days, 1 week, and 2 weeks after the operation. Data represent the mean ± SEM of five rats.
aP < 0.05, significantly different from sham (Student unpaired t test).
nephropathy. The mRNA expression of DR-NR #2 and
#3 was significantly decreased in the cisplatin, but not the
vancomycin nephropathy. There were no changes in the
mRNA expression of UR-NR #2 and DR-NR #1 among
the three treated groups.
Structure of unknown genes
UR-NR #1, UR-NR #2, DR-NR #1, DR-NR #2, and
DR-NR #3 were fully isolated by the 5′ RACE technique.
They were all highly homologous to the mouse or human
putative clone in which only nucleic acid sequences were
identified. Their deduced amino acid sequences were also
highly homologous to the putative proteins correspond-
ing to the putative nucleotide (Table 7). Figure 6 shows
their deduced amino acid sequences, and the conserved
domains are listed in Table 8. The topologies of these
five proteins were predicted by SOSUI system, which is
a tool for secondary structure prediction of membrane
proteins (www.sosui.proteome.bio.taut.ac.jp, Mitaku and
Hirokawa, 1999). DR-NR #3 was found to be a
membrane-bound protein. DR-NR #1 was predicted to
be a secreted protein, but the other three proteins were
thought to be soluble proteins. UR-NR #1 consisted
of 1075 bp nucleotides, and contained an open reading
frame of 117 amino acids. UR-NR #1 did not show any
significant similarity with known genes and conserved
domains (Fig. 6A). UR-NR #2 consisted of 3752 bp nu-
cleotides, and contained an open reading frame of 353
amino acids. A conserved domain search revealed that
UR-NR #2 had a Tre/Bub2/Cdc16 (TBC) domain, which
was the guanosine triphosphatase (GTPase) activator
protein of Rab-like small GTPases (Rab-GAPs), regu-
lators of intracellular vesicle trafficking (Fig. 6B) [27].
DR-NR #1 consisted of 3315 bp nucleotides, contained
an open reading frame of 297 amino acids, and had a con-
served domain of isochorismatase, a family of hydrolase
enzymes (Fig. 6C) [28]. DR-NR #2 consisted of 3032 bp
nucleotides, and contained an open reading frame of 596
amino acids (Fig. 6D). DR-NR #2 had a conserved do-
main of Rho-GAPs, which negatively regulated Rho [29,
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Fig. 3. Detection of mRNA of the five unknown genes in rat tissues
by reverse transcription-polymerase chain reaction (RT-PCR). Total
RNA (5 lg) from the tissues indicated was reverse-transcribed, and
the cDNA synthesized was amplified using a set of primers specific
for each clone. The PCR products were separated by electrophoresis
through 1% agarose gels and stained with ethidium bromide. Abbrevi-
ations are: −RT, whole kidney without reverse transcriptase; UR-NR
#1, up-regulated 5/6 nephrectomized #1; UR-NR #2, up-regulated 5/6
nephrectomized #2; DR-NR #1, down-regulated 5/6 nephrectomized
#1; DR-NR #2, down-regulated 5/6 nephrectomized #2; DR-NR #3,
down-regulated 5/6 nephrectomized #3; GADPH, glyceraldehyde-3-
phosphate dehydrogenase.
30]. DR-NR #3 consisted of 1753 bp nucleotides, and con-
tained an open reading frame of 324 amino acids (Fig. 6E).
DR-NR #3 contained a typical NADP+-binding motif
(TGxxxGxG) and a short chain dehydrogenase active site
motif (S-Y-K) [31]. In addition, 101 amino acids of DR-
NR #3, from 89 to 189, were very similar to “hypertension-
induced rat S2 protein,” which was previously reported to
be up-regulated in spontaneously hypertensive rats [32].
The similarity was approximately 98% in the matched re-
gion, totaling 31% homology (Fig. 6E). Therefore, DR-
NR #3 would be a full length of rat S2 protein.
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Fig. 4. Detection of mRNA of the five un-
known genes in nephron segments in sham
(A) and 5/6 nephrectomized (NR) kidney
(B) 2 weeks after the operation by reverse
transcription-polymerase chain reaction (RT-
PCR) and subsequent Southern blotting.
Each PCR amplification (35 cycles) was per-
formed using a part of the reverse transcrip-
tion reaction derived from 20 glomeruli or
8 mm length of renal tubule. The cDNA syn-
thesized was amplified using sets of primers
specific for each clone. The PCR products
were separated by electrophoresis through
1.0% agarose gels. The agarose gels were
transferred onto a nylon membrane and
hybridized with the [32P] deoxycytidimine
triphosphate (dCTP)-labeled each cDNA as
probes at high stringency. Abbreviations are:
Glm, glomerulus; PCT, proximal convoluted
tubule; PST, proximal straight tubule; MAL,
medullary thick ascending limb; CAL, cor-
tical thick ascending limb; CCD, cortical
collecting duct; OMCD, outer medullary col-
lecting duct; IMCD, inner medullary collect-
ing duct; −RT, whole kidney without reverse
transcriptase; UR-NR #1, up-regulated 5/6
nephrectomized #1; UR-NR #2, up-regulated
5/6 nephrectomized #2; DR-NR #1, down-
regulated 5/6 nephrectomized #1; DR-NR #2,
down-regulated 5/6 nephrectomized #2; DR-
NR #3, down-regulated 5/6 nephrectomized
#3; GADPH, glyceraldehyde-3-phosphate
dehydrogenase.
Table 6. State of renal function of rats treated with cisplatin or vancomycin
Body Plasma creatinine Blood urea Creatinine clearance Urinary excretion Urinary excretion Kidney
weight g mg/dL nitrogen mg/dL mL/min/kg of albumin mg/day of NAG U/day weight g
Vehicle 333 ± 8 0.7 ± 0.0 13 ± 2 3.2 ± 0.1 0.8 ± 0.3 277 ± 32 2.2 ± 0.1
Cisplatin 268 ± 5a 2.7 ± 0.3a 105 ± 15a 0.5 ± 0.1a 3.5 ± 0.8a 1093 ± 241a 2.2 ± 0.1
Vancomycin 320 ± 11 0.8 ± 0.1 28 ± 4a 3.3 ± 0.4 1.9 ± 0.8 582 ± 41a 2.9 ± 0.2a
NAG is N-acetyl-b-D-glucosaminidase.
Rats were treated with cisplatin (6 mg/kg) intraperitonealy, vancomycin (500 mg/kg) intravenously or vehicle (saline) intravenously. Urine and blood samples were
collected 3 days after the treatments. Data represent the mean ± SEM of five rats.
aP < 0.05, significantly different from vehicle (Fisher’s t test).
DISCUSSION
Large-scale cDNA expression profiling was performed
to construct the expression profiles of 5/6 nephrectomized
and sham-operated kidney. In the 5/6 nephrectomized
kidney, the expression of growth factor-related mRNA
such as for IGF, IGFBPs, and TGF-b , which are known to
directly up-regulate cell growth was increased compared
to that in the sham-operated kidney (Table 1) [3, 6, 33, 34].
It is known that compensatory hypertrophy occurs at 2
weeks after nephrectomy [2]. The increase in the expres-
sion of growth factor–related genes might correspond to
the compensatory hypertrophy. The mRNA-encoded cy-
toskeletal or membrane proteins were also increased in
the 5/6 nephrectomized kidney compared to the sham-
operated kidney. The increases of these mRNAs were
thought to be due to the process of tissue repair and hy-
pertrophy. In contrast to the above genes, the mRNA ex-
pression frequency related to transporters and cofactors
of transporters such as OCTN2 and 4F2hc, was decreased
in the 5/6 nephrectomized kidney (Table 1). Our previ-
ous reports demonstrated that the mRNA of the organic
anion and the cation transporters, OAT-K and OCT2,
was down-regulated, accompanied by a decrease in the
urinary excretion of methotrexate and cimetidine, respec-
tively, in the 5/6 nephrectomized rats [9, 10]. The decrease
in transporter-related genes shown in this study might ac-
count for the reduction of urinary excretion of various
drugs in CRF. Taken together, these changes observed in
the 5/6 nephrectomized and in the sham-operated kidney
databases could account for the physiologic state of the
residual kidneys in 5/6 nephrectomized rats.
To confirm whether the in silico subtractive database
of 5/6 nephrectomized kidney reflected the actual expres-
sion of mRNA or protein, the expression of 12 genes,
which have been considered to play significant roles in
the kidney, was examined by Northern blotting or West-
ern blotting in the 5/6 nephrectomized and in the sham-
operated kidney (Table 4). The differential expression
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Fig. 5. Northern blotting of the five unknown genes in the rats treated with cisplatin or vancomycin. Expression of up-regulated 5/6 nephrectomized
(UR-NR) #1 mRNA (A), up-regulated 5/6 nephrectomized (UR-NR) #2 mRNA (B), down-regulated 5/6 nephrectomized (DR-NR) #1 mRNA
(C), down-regulated 5/6 nephrectomized (DR-NR) #2 mRNA (D), down-regulated 5/6 nephrectomized (DR-NR) #3 (E), and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA (F) in vehicle, cisplatin, or vancomycin-treated rat kidneys was examined. Five micrograms of total
RNA of kidneys was hybridized with each probe under high stringency conditions. The amounts of mRNA were quantified by densitometry and
normalized to GAPDH. Each column represents the mean ± SEM of four rats. ∗P < 0.05, significantly different from vehicle-treated rats (Fisher’s
t test).
patterns of these 12 genes between the 5/6 nephrec-
tomized and sham-operated kidney databases were
comparable with the results of Northern blotting and
Western blotting (Fig. 1). Thus, the results indicated that
the frequency shown in this subtractive database was reli-
able enough to estimate actual expression of mRNA and
protein.
Digital expression profiling has been used to analyze
gene expression on a large scale [15–18]. With this tech-
nique, cDNA was digested by the restriction enzyme
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Table 7. The orthologues of the five unknown putative proteins
Accession number of orthologuesAccession
Clone ID number Gene name of orthologues Homology Nucleotide Protein
UR-NR #1 AB108667 Mus musculus 10 days embryo putative protein 97% AK012030 BAB27984
UR-NR #2 AB108668 Mus musculus clone MGC:11983 97% BC011420 AAH11420
DR-NR #1 AB108669 Mus musculus NN5H6H tumor-related protein mRNA 99% AY035213 AAK64607
DR-NR #2 AB108670 Homo sapiens hypothetical protein DKFZp564B1162 82% NM 031305 NP 112595
DR-NR #3 AB108671 Homo sapiens CGI-86 protein 61% XM 055115 XP 055115
The ortholog of the five unknown deduced amino acid proteins differentially expressed in the 5/6 nephrectomized kidney are listed. Homology was estimated by
GENETYX-MAC, version 10.1.
E
D
C
B
A Fig. 6. The deduced amino acid sequences
of the five unknown genes. (A) Up-regulated
5/6 nephrectomized (UR-NR) #1 encoded
a putative protein of 117 amino acids that
are shown in the one-letter code. (B) Up-
regulated 5/6 nephrectomized (UR-NR) #2
encoded a putative protein of 353 amino acids
that are shown in the one-letter code. The
region in bold is highly homologous with
the TBC domain. (C) Down-regulated 5/6
nephrectomized (DR-NR) #1 encoded a puta-
tive protein of 298 amino acids that are shown
in the one-letter code. The region in bold is
highly homologous with the conserved do-
main of isocholismatase. (D) Down-regulated
5/6 nephrectomized (DR-NR) #2 encoded a
putative protein of 596 amino acids that are
shown in the one-letter code. The region in
bold is highly homologous with the conserved
domain of Rho-GAPs. (E) Down-regulated
5/6 nephrectomized (DR-NR) #3 encoded a
putative protein of 324 amino acids that are
shown in the one-letter code. The sequences
of TGxxxGxG (boxed with a thick line and in
bold) indicate the NADPH binding site. The
sequences of S-Y-K (bold region) indicate the
short chain dehydrogenase active site motif.
An alignment with rat S-2 protein is also pre-
sented. Conserved residues between two pro-
teins are boxed.
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Table 8. The conserved domains of the five unknown deduced amino
acid proteins
Accession
Clone ID Region Definition E value number
UR-NR #1a — — — —
UR-NR #2 58–294 TBC domain 6.0E-42 pfam00566
DR-NR #1 109–265 Isochorismatase 1.3E-07 pfam00857
family
DR-NR #2 1–173 RhoGAP domain 2.0E-44 pfam00620
DR-NR #3 48–294 Short chain 2.3E-46 pfam00106
dehydrogenase
Motifs of the five unknown putative proteins were searched against the Smart
and Pfam libraries.
aThere was no conserved domain in UR-NR #1.
MboI and sequenced from the 3′ end. However, in our
study, cDNA libraries were constructed without cleaving
using MboI, and the cDNA inserts were sequenced from
the 5′ end. In many cases the sequenced region from the
5′ end is different in the same genes, because full-length
cDNAs are not always isolated. However, the identity
of two genes in which sequenced regions are different
can be easily examined by homology search, because the
number of enrolled genes in Genbank, EMBL, or DDBJ
has markedly increased recently. In this study, the genes
not identified by BLAST search were further sequenced
from the 3′ end to determine their identity. So, the se-
quence from the 5′ end used in this study should be suit-
able for digital expression profiling. In a previous digital
expression profiling, about 70% of mouse renal proximal
tubule genes and renal collecting duct genes were novel
genes unidentified by homology search [17, 18]. In con-
trast, only 17% of 2048 sequenced genes were novel in
the present study (Table 1). It was reported that the non-
coding regions of the 3′ end are sometimes variant among
species or tissues [35, 36]. This might be one of the rea-
sons why there were so many novel genes not identified
by BLAST search in previous studies. Consequently, the
sequence from the 5′ end appeared to be more useful for
digital expression profiling.
Although a previous report mentioned that cleaving
cDNA by MboI could normalize the cloning efficien-
cies reflecting the size or base composition of cDNA
[15], we constructed cDNA libraries without cleaving
to sequence from the 5′ end. Nevertheless, this sub-
tractive database of 5/6 nephrectomized kidney well re-
flected the actual expression of mRNA or protein as
mentioned above. In addition, GAPDH mRNA, which
is abundantly and ubiquitously expressed and often used
as an internal control, appeared both in the 5/6 nephrec-
tomized and sham-operated kidney databases four and
six times, respectively (Table 4). However, abundantly
appearing GAPDH was not observed in other digital ex-
pression profiles [15, 17, 18]. Although the reason for
the difference between this study and the other stud-
ies remains unknown, the results of the present study
are thought to more reasonably reflect the actual mRNA
expression.
A subtractive analysis of 5/6 nephrectomized mouse
kidney using the cDNA-RDA technique has been re-
ported by Zhang et al [19]. Several genes up-regulated in
the 5/6 nephrectomized mouse kidney were successfully
isolated, but genes previously known to increase after
5/6 nephrectomy were not isolated in their study. In con-
trast, in our study, KIM-1 and osteopontin mRNA, which
were reported to increase upon renal injury [37–39], also
increased in the 5/6 nephrectomized kidney database
(Table 2). This subtractive database reflected previ-
ous reports on the 5/6 nephrectomized rat, and might
be useful to search for the molecular mechanisms of
CRF.
We successfully isolated five unknown genes expressed
differently between in the 5/6 nephrectomized and sham-
operated kidney by in silico subtraction (Fig. 2). The ratio
of false positive clones that failed to show their up- or
down-regulated expression was 70% (13 clones out of
18), which was much lower than that of the previous re-
ports (over 80%) in which differential display was used
[19, 40, 41]. Although all five are highly homologous to
known human or mouse genes, little information is avail-
able concerning the functions and tissue distributions of
these hypothetical genes. Their expression patterns in the
earlier phase of 5/6 nephrectomized kidney and other re-
nal failure models might be useful to speculate their roles
in such conditions as hypertrophy of kidneys, tissue re-
pair, blood pressure, and albuminuria. The precise phys-
iologic roles of these five genes could not be discussed
only from these expression data and the structure. How-
ever, it could be speculated that DR-NR #3 might serve
as a biomarker for renal tubular injury by CRF, such as
KIM-1, which is a transmembrane protein of proximal
tubule and is thought to serve as a urinary marker for
acute renal tubular injury [42]. In addition, UR-NR #2
and DR-NR #1 might be involved in the pathology in-
duced by the reduction of renal mass, because the mRNA
expression level of these two genes was maintained in the
kidneys impaired by cisplatin or vancomycin (Fig. 5B and
C). Particularly, UR-NR #2 might be involved in the com-
pensatory hypertrophy, as it was sequentially increased
in 5/6 nephrectomized kidneys in parallel to the kidney
weights. Further physiologic or pathophysiologic studies,
including the individual variations of expression levels,
are needed to elucidate the roles of these five unknown
genes in the progressive nephropathy.
Digital databases based on random sequencing reflect
the mRNA expression profiles for relatively highly ex-
pressed genes [17, 18, 20]. Although we performed in
silico subtraction only between 5/6 nephrectomized and
sham-operated kidney databases, this methodology en-
ables us to create disease-specific gene subsets using var-
ious disease models, as well as body mapping [15, 16].
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CONCLUSION
We constructed subtractive expression databases of 5/6
nephrectomized and sham-operated kidney, which re-
flected the actual alterations of mRNA expression caused
by subtotal nephrectomy, and was suggested to be use-
ful for analysis of the molecular mechanisms of CRF.
In addition, we successfully isolated five unknown genes
expressed differently in the 5/6 nephrectomized kidney
from in silico subtraction, two of which were up-regulated
and three down-regulated. Although these five genes
might be involved in the progression and/or restoration
of CRF, further studies are needed to elucidate their roles
in the pathogenesis of CRF.
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